Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06843538 · ClinicalTrials.gov registry record · Phase 3
Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
A Phase 3 study of Postoperative Urinary Retention (POUR), sponsored by TriHealth.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 166
- Enrollment target
- 1
- Study location
NCT06843538 is a Phase 3 study of Postoperative Urinary Retention (POUR) that is actively recruiting participants, run by TriHealth. The registered enrollment target is 166 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06843538, a Phase 3 study of Postoperative Urinary Retention (POUR), is actively recruiting participants, sponsored by TriHealth.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 166 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Study Locations (1)
Ohio
- TriHealth - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 166 participants |
| Start Date | 2025-02-03 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06843538
The ClinicalTrials.gov registry entry for NCT06843538 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 166 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Urinary Retention (POUR) appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06843538 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT06843538 about?
NCT06843538 is a clinical study titled "Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery". The purpose of this research study is to determine if taking tamsulosin preoperatively decreases your chances of being discharged after surgery with a Foley catheter (flexible tube that drains urine from the bladder into a collection bag).
What is the current status of trial NCT06843538?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 166 participants. The study started on 2025-02-03. Estimated completion is 2026-06-01.
What conditions does trial NCT06843538 study?
This clinical trial studies the following conditions: Postoperative Urinary Retention (POUR).
What interventions are being tested in trial NCT06843538?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT06843538?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06843538 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.